News

Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...
In 2020, an unadjusted mean annual rate of functional decline measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale ... with slower and slowest changes seen in bulbar and ...
Their clinical characteristics were compared with the amyotrophic lateral sclerosis (ALS) group as a whole ... with little or no functional impairment of the bulbar muscles ...
The aim of the group is to decipher the role of intercellular communication in different physiological and pathological conditions such as Amyotrophic Lateral Sclerosis (ALS), Spinal and Bulbar ...
Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...
MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...
Scientists at Northwestern University have developed a new approach that directly combats the progression of ...
Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...
Jeffrey Birkel, who has ALS, finished the 2025 Boston Marathon to raise awareness about the disease, using a race wheelchair pushed by his sons.
Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct. 21, 2024 — New research has revealed a connection between ancient viral DNA embedded in ...